News

The central government has regulated prices for 71 essential medicines. This includes drugs for breast cancer, allergies, and diabetes. Reliance Life Sciences' Trastuzumab is now capped at Rs 11,966 ...
Fact checked by Stella Osoba In 2015, Martin Shkreli captured national headlines when he raised the price of a life-saving medication by 5,000%—from $13.50 to $750 per pill. But the audacious price ...
The Trump administration recently released an executive order directing Medicare and Medicaid drug reimbursement to be based on prices in other countries, using a model called Most Favored Nation ...
The National Pharmaceutical Pricing Authority (NPPA) has notified retail prices of 41 new drugs including various anti-diabetic, antibiotic drug combinations after a latest Authority meeting held ...
For years, Congress has singled out pharmacy benefit managers, holding 20 hearings while calling on drug companies only a handful of times to explain their prices and business practices.
Continuing high prices and demand for GLP-1 weight-loss drugs is creating lots of questions about the affordability of these drugs for U.S. healthcare consumers.
Section 5: Directs HHS to communicate most-favored-nation price targets to pharmaceutical manufacturers For more information about the May 12 order, please see “ How Trump’s Latest Drug Price ...
Median annual list price for new drugs over $370,000 in 2024 72% of new drugs in 2024 for orphan diseases Drugmakers emphasize value, offer savings programs amid rising list prices May 22 (Reuters ...
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26.
President Donald Trump signed an executive order that claims to force Big Medicine to lower prescription drug prices paid by Americans to the prices paid by other countries.
Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing negotiations by Feb. 1. Read more here.
Health and Human Services Secretary Robert F. Kennedy Jr. said that bringing the cost of prescription drugs to levels seen in Europe largely depends on how drug companies cooperate.